Physician profile
Neel V Parekh
NPI 1164765277
$133,366.16
in general payments reported to CMS, 2019-2025
30 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,111 · 2020: $3,094 · 2021: $2,348 · 2022: $36K · 2023: $50K · 2024: $23K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $57K · Food and Beverage: $13K · Travel and Lodging: $7,856 · Consulting Fee: $6,526 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,988 · Education: $30.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $57,200.00 |
| Food and Beverage | $12,758.36 |
| Travel and Lodging | $7,856.03 |
| Consulting Fee | $6,526.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,988.48 |
| Education | $30.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $103,226.07 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Boston Scientific Corporation | $20,378.78 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, Ams 700, General - Erectile Dysfunction |
| Coloplast Corp | $2,980.40 | 2021-2025 | Titan |
| Olympus America INC. | $1,426.67 | 2022-2025 | Itind System |
| Procept Biorobotics Corporation | $654.42 | 2021-2024 | Aquabeam System, Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $544.14 | 2020-2024 | Xiaflex, Aveed |
| Biotissue Holdings INC. | $519.44 | 2021-2025 | |
| Astellas Pharma US INC | $395.51 | 2020-2022 | |
| Teleflex LLC | $394.02 | 2021-2024 | Urolift |
| Sumitomo Pharma America, INC. | $289.02 | 2023-2025 | Gemtesa, Orgovyx |
| Neotract INC. | $250.07 | 2019 | |
| Edap Technomed INC | $248.00 | 2023 | |
| Tolmar, INC. | $241.21 | 2023-2025 | Jatenzo, Eligard, Rubraca |
| Halozyme INC | $220.07 | 2023 | |
| Aroa Biosurgery Incorporated | $188.81 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $186.98 | 2024-2025 | Xiaflex |
| Urogen Pharma, INC. | $178.75 | 2024-2025 | |
| Calyxo, INC. | $173.91 | 2024-2025 | Cvac Aspiration System |
| Dornier Medtech America, INC | $156.67 | 2023 | Dornier Medtech |
| Kerecis Limited | $124.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Myovant Sciences INC. | $118.99 | 2022 | |
| Bard Access Systems, INC. | $100.00 | 2019 | |
| Cook Medical LLC | $95.77 | 2022 | |
| Photocure INC | $65.20 | 2024 | Cysview |
| Caldera Medical, INC | $64.83 | 2022 | |
| Progenics Pharmaceuticals, INC. | $63.72 | 2023 | Pylarify |
| C. R. Bard, INC. & Subsidiaries | $30.32 | 2024 | Bard Urinary Drainage Bag |
| Pharmaand Gmbh | $21.78 | 2025 | Rubraca |
| Ethicon US, LLC | $14.47 | 2025 | Echelon; Endopath |
| Medtronic USA, INC. | $14.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Parekh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.